NPCE NeuroPace, Inc.
12.87USD+1.58%Mkt Cap: 434.89M $P/E: —1d ago
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap434.89M USD
Enterprise Value453.12M USD
Revenue (TTM)106.99M USD
Gross Profit77.22M USD
Net Income (TTM)-21.46M USD
Revenue/Share3.19 USD
Last Price12.87 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees220
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-58.26
PEG—
EV/EBITDA-38.15
EV/Revenue4.24
P/S4.06
P/B36.51
EPS (TTM)-0.55
EPS (Forward)-0.22
52W Range
9.22035% of range19.60
52W High19.60 USD
52W Low9.220 USD
Profitability
Gross Margin77.23%
Oper. Margin-22.53%
EBITDA Margin-11.10%
Profit Margin-21.47%
ROE-112.79%
ROA-20.33%
Growth
Revenue Growth17.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.01M USD
CapEx (TTM)332.00K USD
FCF Margin-2.46%
FCF Yield-0.60%
Net Debt18.23M USD
Net Debt/EBITDA-1.54
Balance Sheet
Debt/Equity3.72
Current Ratio4.94
Quick Ratio3.82
Book Value/Sh0.35 USD
Cash/Share1.51 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)20.00 USD
Upside (mean)+55.4%
Target Range18.00 USD – 22.00 USD
18.00+55.4% to mean22.00
# Analysts10
Ownership
Shares Out.34.32M
Float25.52M
Insiders4.47%
Institutions97.33%
Short Interest
Short Ratio7.3d
Short % Float3.21%
Short % Out.2.79%
Shares Short956.22K
Short (prev mo.)845.37K
Technical
SMA 5014.25 (-9.7%)
SMA 20015.30 (-15.9%)
Beta1.87
S&P 52W Chg16.45%
Avg Vol (30d)136.10K
Avg Vol (10d)156.70K
Technical Indicators
RSI (14)35.4
MACD-0.4232
MACD Signal-0.2769
MACD Hist.-0.1463
BB Upper15.30 USD
BB Middle14.01 USD
BB Lower12.73 USD
BB Width18.36%
ATR (14)0.6227 USD
Vol Ratio (20d)0.60x